Inhibition of cyclo-oxygenase and lipoxygenase reviewed

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1317, 2001-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A pyrroloquinazoline derivative with anti-inflammatory and analgesic activity by dual inhibition of cyclo-oxygenase-2 and 5-lipoxygenase

By Rioja I. Terencio M.C. Ubeda A. Molina P. Tarraga A. Gonzalez-Tejero A. Alcaraz M.J.

European Journal of Pharmacology, Vol. 434, Iss. 3, 2002-01 ,pp. : 177-185

Elsevier

Access to resources Recommend Favorite

Combined Lipoxygenase/Cyclo-oxygenase Inhibition in the Elderly: The Example of Licofelone

By Cicero Arrigo F.G.

Drugs & Aging, Vol. 22, Iss. 5, 2005-01 ,pp. : 393-403

Adis International

Access to resources Recommend Favorite

Cyclo-Oxygenase-2 and its Inhibition in Cancer: Is There a Role?

By Liao Zhongxing

Drugs, Vol. 67, Iss. 6, 2007-01 ,pp. : 821-845

Adis International

Access to resources Recommend Favorite

The pharmacological profile of ML3000: A new pyrrolizine derivative inhibiting the enzymes cyclo-oxygenase and 5-lipoxygenase

By Tries S.

Inflammopharmacology, Vol. 9, Iss. 1-2, 2001-05 ,pp. : 113-124

VSP

Access to resources Recommend Favorite

Thrombin-stimulated DNA Synthesis in Human Cultured Airway Smooth Muscle Occurs Independently of Products of Cyclo-oxygenase or 5-Lipoxygenase

By Fernandes D. Vlahos R. Stewart A.G.

Pulmonary Pharmacology & Therapeutics, Vol. 13, Iss. 5, 2000-09 ,pp. : 241-248

Academic Press

Access to resources Recommend Favorite